Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole

Clinical Science

Volumn 105, Issue 4, 2003, Pages 513-518

  Passauer, Jens ^a   Büssemaker, Eckhart ^a   Lässig, Grit ^a   Pistrosch, Frank ^a   Fauler, Joachim ^b   Gross, Peter ^a   Fleming, Ingrid ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Bradykinin; Cytochrome P450; Endothelium derived hyperpolarizing factor; Forearm; Sulphaphenazole; Vasodilatation

Indexed keywords

BRADYKININ; CYTOCHROME P450 2C9; IBUPROFEN; JENAPROFEN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; SULFAPHENAZOLE;

ADULT; ARTICLE; BLOOD FLOWMETRY; BRACHIAL ARTERY; CONTROLLED STUDY; DEVICE; DRUG EFFECT; DRUG INFUSION; DRUG SENSITIVITY; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; ARYL HYDROCARBON HYDROXYLASES; BRADYKININ; CYCLOOXYGENASE INHIBITORS; FOREARM; HUMANS; IBUPROFEN; MALE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; SULFAPHENAZOLE; VASODILATOR AGENTS;

EID: 0141888501     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030118     Document Type: Article

References (25)

1. Busse, R. and Fleming, I. (1996) Endothelial dysfunction in atherosclerosis. J. Vasc. Res. 33, 181-194
2. Fleming, I. (2000) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Trends Cardiovasc. Med. 10, 166-170
3. McGuire, J. J., Ding, H. and Triggle, C. R. (2001) Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can. J. Physiol Pharmacol. 79, 443-470
4. Quilley, J., Fulton, D. and McGiff, J. C. (1997) Hyperpolarizing factors. Biochem. Pharmacol. 54, 1059-1070
5. Triggle, C. R., Dong, H., Waldron, G. J. and Cole, W. C. (1999) Endothelium-derived hyperpolarizing factor(s): species and tissue heterogeneity. Clin. Exp. Pharmacol. Physiol. 26, 176-179
6. Busse, R., Edwards, G., Feletou, M., Fleming, I., Vanhoutte, P. M. and Weston, A. H. (2002) EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23, 374-380
7. Fisslthaler, B., Popp, R., Kiss, L. et al. (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature (London) 401, 493-497
8. Campbell, W. B. and Harder, D. R. (1999) Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ. Res. 84, 484-488
9. + channels by cytochrome P-450 inhibitors. J. Biol. Chem. 267, 11789-11793
10. Mancy, A., Dijols, S., Poli, S., Guengerich, P. and Mansuy, D. (1996) Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry 35, 16205-16212
11. Sai, Y., Dai, R., Yang, T. J. et al. (2000) Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica 30, 327-343
12. Fisslthaler, B., Hinsch, N., Chataigneau, T. et al. (2000) Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 36, 270-275
13. Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P. and Webb, D. (1995) Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25, 918-923
14. Carlsson, I. and Wennmalm, A. (1983) Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. Prostaglandins 26, 241-252
15. G-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br. J. Pharmacol. 134, 939-944
16. Bowman, W. C. and Rand, M. J. (1984) Textbook of Pharmacology, University Press, Cambridge
17. Hillig, T., Krustrup, P., Fleming, I., Osada, T., Saltin, B. and Hellsten, Y. (2003) Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans. J. Physiol. (Cambridge, U.K.) 546, 307-314
18. Honing, M. L., Smits, P., Morrison, P. J. and Rabelink, T. J. (2000) Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension 35, 1314-1318
19. Ca channels. Circulation 107, 769-776
20. Halcox, J. P., Narayanan, S., Cramer-Joyce, L., Mincemoyer, R. and Quyyumi, A. A. (2001) Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am. J. Physiol. Heart Circ. Physiol. 280, H2470-H2477
21. Bauersachs, J., Popp, R., Hecker, M., Sauer, E., Fleming, I. and Busse, R. (1996) Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94, 3341-3347
22. Taddei, S., Ghiadoni, L., Virdis, A., Buralli, S. and Salvetti, A. (1999) Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 100, 1400-1405
23. Taddei, S., Virdis, A., Ghiadoni, L. et al. (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274-279
24. + channels. Circulation 103, 1992-1998
25. Fleming, I., Michaelis, U. R., Bredenkotter, D. et al. (2001) Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ. Res. 88, 44-51